Home › NDC Lookup › RxCUI directory › RxCUI 2572114

Benzalkonium chloride 1.3 MG/ML / benzocaine 50 MG/ML Topical Solution — RxCUI 2572114

RxNorm drug concept · Semantic clinical drug
RxCUI 2572114 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2572114
Official nameBenzalkonium chloride 1.3 MG/ML / benzocaine 50 MG/ML Topical Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbenzalkonium chloride 0.13 % / benzocaine 5 % Topical Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Benzalkonium chloride 1.3 MG/ML / benzocaine 50... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Benzalkonium chloride 1.3 MG/ML / benzocaine 50 MG/ML Topical Solution RxCUI 2572114

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Benzalkonium 1378
    • Benzocaine 1399
    • Benzalkonium / benzocaine 1009089
    • Benzalkonium chloride 1379
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Benzalkonium / benzocaine Topical Solution 864743
    • Benzalkonium chloride / benzocaine Topical Solution 2649457
    • Benzalkonium / benzocaine Topical Product 1151327
    • Benzalkonium chloride / benzocaine Topical Product 2661622
    • Topical Solution 316986
    • Topical Product 1151122
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Benzalkonium chloride 1.3 MG/ML 997657
    • Benzocaine 50 MG/ML 329214

Showing up to 8 concepts per family — 12 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Benzalkonium chloride 1.3 MG/ML SCDC · 997657
  • Benzocaine 50 MG/ML SCDC · 329214
  • Benzalkonium / benzocaine Topical Solution SCDF · 864743
  • Benzalkonium chloride / benzocaine Topical Solution SCDFP · 2649457
  • Benzalkonium / benzocaine Topical Product SCDG · 1151327
  • Benzalkonium chloride / benzocaine Topical Product SCDGP · 2661622

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2572114 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
10237-0798-35 6 VIAL, SINGLE-DOSE in 1 PACKAGE (10237-798-35) / 3.5 mL in... Orajel Cold Sore Touch Free - Single Dose Church & Dwight Co., Inc. 2021-09-01
Observed labelers: Church & Dwight Co., Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.